Cardiovascular Risk Profile of Antirheumatic Agents in Patients with Osteoarthritis and Rheumatoid Arthritis

Author： Nurmohamed M.T.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.62, Iss.11, 2002-01, pp. : 1599-1609

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Will Antirheumatic Treatment Improve Cardiovascular Outcomes in Patients with Rheumatoid Arthritis?

By  

Current Pharmaceutical Design, Vol. 20, Iss. 4, 2014-02 ,pp. : 486-495

Bentham Science Publishers

Access to resources Recommend Favorite

Safety and efficacy of disease-modifying antirheumatic agents in rheumatoid arthritis and juvenile rheumatoid arthritis

By Fleischmann Roy  

Expert Opinion on Drug Safety, Vol. 2, Iss. 4, 2003-07 ,pp. : 347-365

Informa Healthcare

Access to resources Recommend Favorite

Risk : Benefit Profile of Etanercept in Elderly Patients with Rheumatoid Arthritis, Ankylosing Spondylitis or Psoriatic Arthritis

By Fleischmann Roy   Iqbal Imran  

Drugs & Aging, Vol. 24, Iss. 3, 2007-01 ,pp. : 239-254

Adis International

Access to resources Recommend Favorite

Nabumetone: Therapeutic Use and Safety Profile in the Management of Osteoarthritis and Rheumatoid Arthritis

By Thomas Hedner  

Drugs, Vol. 64, Iss. 20, 2004-01 ,pp. : 2315-2343

Adis International

Access to resources Recommend Favorite

Nabumetone: Therapeutic Use and Safety Profile in the Management of Osteoarthritis and Rheumatoid Arthritis

By Sanford H. Roth  

Drugs, Vol. 64, Iss. 20, 2004-01 ,pp. : 2344-2345

Adis International

Access to resources Recommend Favorite